Company news
Shimadzu Corporation news in 2026
Shimadzu Corporation's news releases, calls and decks from 2026, newest first.
Notice Regarding Dividends of Surplus (Interim Dividend) and Revised Year-End Dividend Forecast
November 6, 2026
Consolidated Financial Results for the Six Months Ended September 30, 2026 (Under Japanese GAAP)
November 6, 2026
Supporting Biopharmaceutical Development through AI-Powered Cell Culture Media OptimizationShimadzu Begins Collaboration with Axio BioPharma
November 5, 2026
Shimadzu: Thailand's Deputy Prime Minister Visits Shimadzu CorporationShimadzu Signs Letter of Intent with Thai Research Institutions for Cooperation in Research and Innovation
October 26, 2026
CVC Fund "Shimadzu Future Innovation Fund"Invested in Kinish, which is working on next-generation food development utilizing plant molecular agriculture technology
October 20, 2026
Reorganization of UK Group Companies; Business Operations Commence Under New Structure Enhancing Development Capabilities for Mass Spectrometers and X-ray Photoelectron Spectroscopy Instruments
September 8, 2026
Notice Regarding Additional Contribution for the Continuation of the Share-Based Compensation Plan for Directors and Officers
August 28, 2026
Shimadzu: CVC Fund “Shimadzu Future Innovation Fund” Invests in OptQC, a Developer of Optical Quantum ComputersExpected to Advance Next-Generation R&D Infrastructure for Drug Discovery and Materials Development
August 24, 2026
Consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP)
August 6, 2026
Shimadzu Acquires Czech-Based TESCAN as a Wholly Owned SubsidiaryAcquisition of Electron Microscopy Business Strengthens End-to-End Solutions in Analytical and Measuring Technologies
July 9, 2026
Shimadzu Medical Systems USA announces the release of the FLUOROspeed X1 edition ST
June 17, 2026
New Medium-Term Management Plan for FY 2026 to 2028 PreparedBecome an Innovative Company That Solves Social Challenges Together with Global Partners—Sustainably Improve Profitability by Strengthening End-to-End Solutions Capabilities—
June 10, 2026
Shimadzu Joins NIIMBL to Advance Biopharmaceutical Manufacturing Innovation
May 27, 2026
Shimadzu Acquires German Startup Plasmion GmbH Secures SICRIT Ion Source Technology for Mass Spectrometers
April 26, 2026
Shimadzu: Scientific Instruments Inc. Opens New Laboratory in the San Francisco Bay Area — Accelerating New Product and Business Development for the Pharmaceutical and Life Science Fields —
March 30, 2026
Shimadzu Medical Systems USA renews HCAI Special Seismic Certification Approval for Radiographic System
March 26, 2026
Shimadzu has invested JPY 1 billion in Kyoto University Innovation Capital’s Fund III to support the growth and societal implementation of university-originated startups.
March 15, 2026
Shimadzu: Future Innovation Fund Invests in A-wave, a Startup Developing a System to Reduce Hospital Readmissions for Heart Failure Patients
February 16, 2026
Shimadzu Selected for CDP’s Climate Change “A List,” the Highest Possible Rating
February 9, 2026
Eco-First Company Certification Renewed by the Minister of the Environment
January 12, 2026
Decks in 2026
- Investor Presentation (September 2026)
Investor deck · 23 slides · Sep 4, 2026
- Q1 FY2026 Earnings Presentation
Earnings · 33 slides · Aug 6, 2026
- Q1 FY2026 Earnings Presentation
Earnings · 33 slides · Aug 6, 2026
- Investor Presentation (June 2026)
Investor deck · 45 slides · Jun 4, 2026
- FY2025 Earnings Presentation
Earnings · 42 slides · May 13, 2026
- FY2025 Earnings Presentation
Earnings · 42 slides · May 13, 2026
- Q3 FY2025 Earnings Presentation
Earnings · 35 slides · Feb 5, 2026